US 7781404
IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof
granted A61KA61K38/00
Quick answer
US patent 7781404 (IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00